| Quarter (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| 13F holders | Current |
|---|---|
| Total holders | 95 |
| Opened positions | 24 |
| Closed positions | 22 |
| Increased positions | 36 |
| Reduced positions | 23 |
| 13F shares | Current |
|---|---|
| Total value | 541.81 bn |
| Total shares | 116.22 mm |
| Total puts | 729.40 k |
| Total calls | 625.88 k |
| Total put/call ratio | 1.2 |
| Largest owners | Shares | Value |
|---|---|---|
| dievini Hopp BioTech holding GmbH & Co KG | 17.20 mm | $0.00 |
| T. Rowe Price Investment Management | 10.60 mm | $75.40 mm |
| Wellington Management | 10.42 mm | $74.07 bn |
| Perceptive Advisors | 9.38 mm | $66.72 bn |
| Baker Bros. Advisors | 7.28 mm | $51.73 bn |
| RTW Investments | 6.54 mm | $46.50 bn |
| Vestal Point Capital | 6.28 mm | $44.62 bn |
| Paradigm Biocapital Advisors | 5.41 mm | $38.50 bn |
| Suvretta Capital Management | 5.07 mm | $36.01 bn |
| Athos KG | 4.91 mm | $58.05 mm |
